Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
Xie X, Muruato AE, Zhang X, Lokugamage KG, Fontes-Garfias CR, Zou J, Liu J, Ren P, Balakrishnan M, Cihlar T, Tseng CK, Makino S, Menachery VD, Bilello JP, Shi PY. Xie X, et al. Among authors: tseng ck. bioRxiv [Preprint]. 2020 Jun 23:2020.06.22.165712. doi: 10.1101/2020.06.22.165712. bioRxiv. 2020. Update in: Nat Commun. 2020 Oct 15;11(1):5214. doi: 10.1038/s41467-020-19055-7. PMID: 32607511 Free PMC article. Updated. Preprint.
Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
Xie X, Muruato AE, Zhang X, Lokugamage KG, Fontes-Garfias CR, Zou J, Liu J, Ren P, Balakrishnan M, Cihlar T, Tseng CK, Makino S, Menachery VD, Bilello JP, Shi PY. Xie X, et al. Among authors: tseng ck. Nat Commun. 2021 Jun 21;12(1):3984. doi: 10.1038/s41467-021-24300-8. Nat Commun. 2021. PMID: 34155200 Free PMC article. No abstract available.
Potent in vitro anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin L.
Ashhurst AS, Tang AH, Fajtová P, Yoon M, Aggarwal A, Stoye A, Larance M, Beretta L, Drelich A, Skinner D, Li L, Meek TD, McKerrow JH, Hook V, Tseng CK, Turville S, Gerwick WH, O'Donoghue AJ, Payne RJ. Ashhurst AS, et al. Among authors: tseng ck. bioRxiv [Preprint]. 2020 Dec 24:2020.12.23.424111. doi: 10.1101/2020.12.23.424111. bioRxiv. 2020. Update in: J Med Chem. 2022 Feb 24;65(4):2956-2970. doi: 10.1021/acs.jmedchem.1c01494. PMID: 33398273 Free PMC article. Updated. Preprint.
A Speedy Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors.
Yang KS, Ma XR, Ma Y, Alugubelli YR, Scott DA, Vatansever EC, Drelich AK, Sankaran B, Geng ZZ, Blankenship LR, Ward HE, Sheng YJ, Hsu JC, Kratch KC, Zhao B, Hayatshahi HS, Liu J, Li P, Fierke CA, Tseng CK, Xu S, Liu WR. Yang KS, et al. Among authors: tseng ck. bioRxiv [Preprint]. 2020 Jul 28:2020.07.28.223784. doi: 10.1101/2020.07.28.223784. bioRxiv. 2020. Update in: ChemMedChem. 2021 Mar 18;16(6):942-948. doi: 10.1002/cmdc.202000924. PMID: 32766582 Free PMC article. Updated. Preprint.
A Universal Bacteriophage T4 Nanoparticle Platform to Design Multiplex SARS-CoV-2 Vaccine Candidates by CRISPR Engineering.
Zhu J, Ananthaswamy N, Jain S, Batra H, Tang WC, Lewry DA, Richards ML, David SA, Kilgore PB, Sha J, Drelich A, Tseng CK, Chopra AK, Rao VB. Zhu J, et al. Among authors: tseng ck. bioRxiv [Preprint]. 2021 Jan 20:2021.01.19.427310. doi: 10.1101/2021.01.19.427310. bioRxiv. 2021. Update in: Sci Adv. 2021 Sep 10;7(37):eabh1547. doi: 10.1126/sciadv.abh1547. PMID: 33501450 Free PMC article. Updated. Preprint.
Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune Enhancement.
Chen WH, Tao X, Agrawal A, Algaissi A, Peng BH, Pollet J, Strych U, Bottazzi ME, Hotez PJ, Lustigman S, Du L, Jiang S, Tseng CK. Chen WH, et al. Among authors: tseng ck. bioRxiv [Preprint]. 2020 Jul 5:2020.05.15.098079. doi: 10.1101/2020.05.15.098079. bioRxiv. 2020. Update in: Vaccine. 2020 Nov 3;38(47):7533-7541. doi: 10.1016/j.vaccine.2020.09.061. PMID: 32511385 Free PMC article. Updated. Preprint.
Parsing the role of NSP1 in SARS-CoV-2 infection.
Fisher T, Gluck A, Narayanan K, Kuroda M, Nachshon A, Hsu JC, Halfmann PJ, Yahalom-Ronen Y, Tamir H, Finkel Y, Schwartz M, Weiss S, Tseng CK, Israely T, Paran N, Kawaoka Y, Makino S, Stern-Ginossar N. Fisher T, et al. Among authors: tseng ck. Cell Rep. 2022 Jun 14;39(11):110954. doi: 10.1016/j.celrep.2022.110954. Epub 2022 May 26. Cell Rep. 2022. PMID: 35671758 Free PMC article.
284 results